MedPath

Astellas Pharma A/S

🇩🇰Denmark
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

Completed
Conditions
Chronic Kidney Disease Associated Anemia
First Posted Date
2018-08-23
Last Posted Date
2024-10-31
Lead Sponsor
Astellas Pharma a/s
Target Recruit Count
14415
Registration Number
NCT03643601
Locations
🇸🇪

SE46001, Stockholm, Sweden

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Completed
Conditions
Metastatic Castration Resistant Prostate Cancer
Interventions
First Posted Date
2017-11-01
Last Posted Date
2024-11-21
Lead Sponsor
Astellas Pharma a/s
Target Recruit Count
211
Registration Number
NCT03328364
Locations
🇸🇪

Site SE46001, Malmo, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.